Plasma-derived medicinal products (PDMPs) are essential for treating numerous life-threatening conditions, but the industry is facing mounting pressures due to rising collection costs. A recent study by Bolcato & Jommi (2024) in Frontiers in Pharmacology highlights significant cost drivers contributing to these challenges, including regulatory hurdles, donor shortages, and operational inefficiencies. As plasma center operators navigate these complexities, optimizing operational efficiency is critical to maintaining profitability while ensuring the sustainability of the plasma supply chain.

Understanding Cost Drivers in Plasma Collection

The plasma collection industry faces unique financial burdens compared to traditional pharmaceutical manufacturing. As illustrated in industry cost breakdowns, manufacturing and raw materials account for approximately 57% of expenses in plasma operations, compared to only 14% in traditional pharmaceutical production. The high cost of donor fees, labor, and compliance further exacerbates these challenges.

Bolcato & Jommi (2024) identified key factors leading to rising costs:

Implementing Strategic Solutions to Reduce Costs

At StratOptix Consulting, we specialize in developing tailored strategies to enhance plasma center efficiency. Our operational focus areas can deliver significant savings through the following interventions:

1. Custom Scheduling & Resource Optimization

2. Employee Turnover Reduction

3. Operational Excellence & Best Practices

4. Donor Engagement & Retention Strategies

Future Outlook: Sustainability Through Innovation

The increasing cost of plasma collection is a pressing challenge, but by leveraging operational expertise, plasma centers can significantly enhance cost efficiency. As demand for PDMPs grows, industry stakeholders must invest in effective process improvements to remain competitive. At StratOptix Consulting, our expertise in plasma operations enables us to drive sustainable improvements, ensuring a more resilient and profitable plasma industry.

If you’re ready to explore cost-saving opportunities for your plasma operations, connect with us today to discuss tailored solutions for your business.

References

Bolcato, M., & Jommi, C. (2024). Shortage of plasma-derived medicinal products: what is next? Narrative literature review on its causes and counteracting policies in Italy. Frontiers in Pharmacology.